VXRT · Vaxart, Inc. · Held by Funds
$0.32
+0.00 (+0.00%)
At close · Jul 8
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on management's current plan, the Company expects to have enough cash runway into the second quarter of 2027. If the Company is unable to raise additional capital in sufficient amounts or on acceptable terms, management's plans include further reducing or delaying operating expenses. These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the date of the issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$126.27M
Shares
242.84M
Volume · Jul 8
11.57M
Avg daily vol (3M)
4.77M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding VXRT
3 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | — | 39,212 | $26,166 | 0.28% | Long | 2024-06-30 | |
| iShares Evolved U.S. Innovative Healthcare ETF | — | 1,751 | $6,444 | 0.02% | Long | 2022-07-31 | |
| Guggenheim Active Allocation Fund | GUG | 715 | $461 | 0.00% | Long | 2026-05-29 |
Showing 1–3 of 3 positions